In a transaction worth $5.5 billion, Biocon Ltd. will incorporate Biocon Biologics Ltd. as a fully owned subsidiary, the firm said on Saturday. Through a share exchange of 70.28 Biocon shares for every 100 Biocon Biologics shares, at ₹405.78 per share, Biocon will purchase the remaining shareholding in Biocon Biologics from Serum Institute Life Sciences, … Read more

First, let us talk about Friday’s policy. In contrast to what we anticipated, the RBI maintained its “neutral” position while lowering the policy repo rate by 25 basis points to 5.25 percent. RBI Eases Inflation Outlook It also lowered its inflation prediction for FY26 by 60 basis points to 2.0 percent, which was dovish guidance … Read more

Following the widespread cancellation of IndiGo flights that left hundreds of customers stranded, the Ministry of Civil Aviation stated in a statement that the Government of India has decided to launch a high-level investigation into the disruption. As pilot rostering problems continued to cause widespread flight cancellations—more than 400 on Friday, December 5, 2025—the operations … Read more

As traders continued to concentrate on prospects of a U.S. Federal Reserve rate decrease and anticipated important inflation data, Bitcoin saw a decline on Friday but retained the majority of its gains following a strong midweek comeback. By 09:02 ET (14:02 GMT), the biggest cryptocurrency in the world has dropped 1.4% to $90,639. Earlier this … Read more

The Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory granted Ginkgo Bioworks Holdings (NYSE:DNA) a contract worth up to $47 million, which caused the company’s shares to rise 4.5% in premarket trade on Friday. In order to support the Department of Energy’s Microbial Molecular Phenotyping Capability, the four-year contract entails co-designing, constructing, and integrating … Read more